Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deiciency during GH therapy
- 31 October 1995
- Vol. 17 (4) , 397-401
- https://doi.org/10.1016/s8756-3282(95)00267-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Connective tissue components in serum in multiple myeloma: Analyses of propeptides of type I and type III procollagens, type I collagen telopeptide, and hyaluronanAmerican Journal of Hematology, 1994
- Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptidesBone, 1994
- Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1993
- New markers of bone and collagen turnover in children and adults with growth hormone deficiencyPublished by Oxford University Press (OUP) ,1993
- TRANSIENT DECREASE IN OSTEOCALCIN AND MARKERS OF TYPE 1 COLLAGEN TURNOVER DURING HIGH-DOSE CORTICOSTEROID PULSE THERAPY IN RHEUMATOID ARTHRITISRheumatology, 1993
- Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiencyThe Journal of Pediatrics, 1993
- Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosisJournal of Bone and Mineral Research, 1991
- Longitudinal Assessment of Type I Procollagen in Children with Inflammatory Bowel Disease Subjected to SurgeryJournal of Pediatric Gastroenterology and Nutrition, 1989
- Type 1 procollagen as a biochemical marker of growth in children with inflammatory bowel diseaseThe Journal of Pediatrics, 1986
- The Biosynthesis of Collagen and Its DisordersNew England Journal of Medicine, 1979